MARCIA CLEAVENGER: Open Payments
NPI 1073715322 · SALINA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$798 in 44 payments from 13 companies in 2025. Trend: 2023 $721 · 2024 $504 · 2025 $798
Food & beverage: $798
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $197 |
| Lundbeck LLC | 5 | $101 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $85 |
| Otsuka America Pharmaceutical, Inc. | 4 | $79 |
| ACADIA Pharmaceuticals Inc | 3 | $64 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $60 |
| Alkermes, Inc. | 2 | $43 |
| Neurocrine BioSciences, Inc. | 2 | $42 |
| Teva Pharmaceuticals USA, Inc. | 2 | $35 |
| Janssen Pharmaceuticals, Inc | 2 | $31 |
Products named: VRAYLAR, REXULTI, CAPLYTA, NUPLAZID, TRINTELLIX, INGREZZA, SPRAVATO, FANAPT.
Industry payments across KS — which companies pay providers there.
